| (Values in U.S. Thousands) | Dec, 2022 | Dec, 2021 | Apr, 2021 | Dec, 2020 | Dec, 2022 |
| Sales | 0 | 267 | 0 | 30 | 0 |
| Sales Growth | -100.00% | unch | -100.00% | unch | unch |
| Net Income | -8,599 | -34,339 | -148 | -87 | 0 |
| Net Income Growth | +74.96% | -23,104.22% | -69.75% | unch | unch |
Wesana Health Holdings Inc (WESA.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Wesana Health Holdings Inc is an emerging life sciences company championing the development and delivery of psychedelic and naturally-sourced therapies to treat traumatic brain injury. The Company is developing evidence-based formulations and protocols that empower patients to overcome neurological, psychological, and mental health ailments caused by trauma with the help of extensive clinical research and academic partnerships.